Hyderabad-based pharma player Aurobindo Pharma will be expanding the capacity of its active pharmaceutical ingredients (APIs) unit in Visakhapatnam this fiscal, according to reports. However, the company did not disclose any details of the investment.

"Around 1100 cubic metre capacity is being commissioned from February 2015 at Unit-11 in Vizag," the company's managing director Mr N Govindarajan said while announcing the company's first quarter results, adding that the company has also started investing in fulfilling European requirements at its Vizag facility.

"Apart from that, we have also started investing in Naidupeta for our future requirement of US oral products," he said. The company has doubled its capex plan for this fiscal, taking it to Rs 600 crore as compared to a total capex of Rs 350 crore in FY14.

"The company's new capex, including maintenance, is expected to be in the range of Rs 600 crore for FY 2014-15, which will be evenly spread out over APIs and formulations facilities. The company's operations have resulted in substantial improvement to support the capex through internal cash generation," he further said.